Skip to main content

Aridis Pharmaceuticals, Inc.

ARDSDelisted Sep 8, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001614067

Aridis Pharmaceuticals, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Jun 28, 2024; 18 institutions reported holding it in 13F filings for Q2 2023, worth $392.3K in total; no superinvestor held it.

Q2 2026 vs. Q1 2026

How the institutions holding Aridis Pharmaceuticals, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of ARDS: Q1 2026 compared with Q2 2026
MeasureQ1 2026Q2 2026Change
Holders110
Shares3.00K3.00K0 (0.0%)
Value$1$0−$1 (−100.0%)

New holders (0)

Institutions that held Aridis Pharmaceuticals, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

None.

Sold out (0)

Institutions that held Aridis Pharmaceuticals, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

None.